Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors

Bioorganic & Medicinal Chemistry Letters
2009.0

Abstract

Fatty acid biosynthesis is essential for bacterial survival. Components of this biosynthetic pathway have been identified as attractive targets for the development of new antibacterial agents. FabH, beta-ketoacyl-acyl carrier protein (ACP) synthase III, is a particularly attractive target, since it is central to the initiation of fatty acid biosynthesis and is highly conserved among Gram positive and negative bacteria. Three series of Schiff bases containing thiazole template were synthesized and developed as potent inhibitors of FabH. This inhibitor class demonstrates strong antibacterial activity. Escherichia coli FabH inhibitory assay and docking simulation indicated that the compounds 11 and 18 were potent inhibitors of E. coli FabH.

DOI： 10.1016/j.bmcl.2009.09.111

Knowledge Graph

Similar Paper

Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors
Bioorganic & Medicinal Chemistry Letters 2009.0
Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity
European Journal of Medicinal Chemistry 2014.0
Design, synthesis, and structure–activity relationships of pyrazole derivatives as potential FabH inhibitors
Bioorganic & Medicinal Chemistry Letters 2010.0
Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory
Bioorganic & Medicinal Chemistry Letters 2014.0
Study of acylhydrazone derivatives with deoxygenated seven-membered rings as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors
MedChemComm 2016.0
Design, synthesis and antimicrobial activities evaluation of Schiff base derived from secnidazole derivatives as potential FabH inhibitors
Bioorganic & Medicinal Chemistry 2013.0
Design and synthesis of potent inhibitors of β-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents
European Journal of Medicinal Chemistry 2010.0
Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors
Bioorganic & Medicinal Chemistry 2011.0
Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors
Bioorganic & Medicinal Chemistry 2011.0
Design and synthesis of novel deoxybenzoin derivatives as FabH inhibitors and anti-inflammatory agents
Bioorganic & Medicinal Chemistry Letters 2010.0